Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 17339499)

Published in J Immunol on March 15, 2007

Authors

Qingyong Xu1, Junglim Lee, Ewa Jankowska-Gan, Jackie Schultz, Drew A Roenneburg, Drew A Roennburg, Lynn D Haynes, Satoshi Kusaka, Hans W Sollinger, Stuart J Knechtle, Anne M VanBuskirk, Jose R Torrealba, William J Burlingham

Author Affiliations

1: Department of Surgery, University of Wisconsin, 600 Highland Avenue, Madison, WI 53792, USA.

Articles citing this

Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice. Blood (2009) 1.63

Pretransplant immune regulation predicts allograft outcome: bidirectional regulation correlates with excellent renal transplant function in living-related donor-recipient pairs. Transplantation (2012) 1.63

Early acceptance of renal allografts in mice is dependent on foxp3(+) cells. Am J Pathol (2011) 1.23

Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients. Am J Transplant (2011) 1.18

Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. J Immunol (2012) 1.09

Clinical operational tolerance after renal transplantation: current status and future challenges. Ann Surg (2010) 1.08

The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation. Transplantation (2009) 1.06

Mouse models with human immunity and their application in biomedical research. J Cell Mol Med (2008) 0.99

Segregated regulatory CD39+CD4+ T cell function: TGF-β-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis. J Immunol (2011) 0.99

Linked suppression across an MHC-mismatched barrier in a miniature swine kidney transplantation model. J Immunol (2008) 0.97

Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. Mediators Inflamm (2010) 0.94

Analysis of indirect pathway CD4+ T cells in a patient with metastable tolerance to a kidney allograft: possible relevance to superior graft survival of HLA class II closely matched renal allografts. Transpl Immunol (2009) 0.91

Trans-vivo delayed type hypersensitivity assay for antigen specific regulation. J Vis Exp (2013) 0.89

Dynamics of human regulatory T cells in lung lavages of lung transplant recipients. Transplantation (2009) 0.89

Tolerance in clinical transplantation: progress, challenge or just a dream? Langenbecks Arch Surg (2011) 0.88

Operational Tolerance in Kidney Transplantation and Associated Biomarkers. Clin Exp Immunol (2017) 0.86

Endurance exercise diverts the balance between Th17 cells and regulatory T cells. PLoS One (2013) 0.85

Successful reduction of immunosuppression in older renal transplant recipients who exhibit donor-specific regulation. Transplantation (2009) 0.84

Key role for CD4 T cells during mixed antibody-mediated rejection of renal allografts. Am J Transplant (2014) 0.82

Bidirectional alloreactivity: A proposed microchimerism-based solution to the NIMA paradox. Chimerism (2012) 0.82

HLA-A, -B, and -DR zero-mismatched kidneys shipped to the University of Wisconsin, Madison, 1993-2006: superior graft survival despite longer preservation time. Transplantation (2010) 0.79

Human seminal plasma fosters CD4(+) regulatory T-cell phenotype and transforming growth factor-β1 expression. Am J Reprod Immunol (2012) 0.77

Kinetics of Alloantigen-Specific Regulatory CD4 T Cell Development and Tissue Distribution After Donor-Specific Transfusion and Costimulatory Blockade. Transplant Direct (2016) 0.75

Exosomes: The missing link between microchimerism and acquired tolerance? Chimerism (2015) 0.75

Articles by these authors

Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40

An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol (2010) 3.75

Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 3.59

IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest (2007) 3.31

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant (2003) 2.83

Liver transplantation for the treatment of hepatocellular carcinoma. Oncology (Williston Park) (2011) 2.14

Biologics in organ transplantation. Transpl Int (2012) 2.06

Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg (2011) 1.98

The hairless mouse in skin research. J Dermatol Sci (2008) 1.95

Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood (2009) 1.94

Immune regulation and graft survival in kidney transplant recipients are both enhanced by human leukocyte antigen matching. Am J Transplant (2004) 1.77

Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. Transpl Int (2006) 1.68

Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg (2005) 1.67

Developmental exposure to noninherited maternal antigens induces CD4+ T regulatory cells: relevance to mechanism of heart allograft tolerance. J Immunol (2007) 1.64

Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with co-administration of cyclosporine A. J Invest Dermatol (2008) 1.64

Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice. Blood (2009) 1.63

Pretransplant immune regulation predicts allograft outcome: bidirectional regulation correlates with excellent renal transplant function in living-related donor-recipient pairs. Transplantation (2012) 1.63

A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients. Clin Cancer Res (2004) 1.55

IFN-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice. Blood (2004) 1.52

Evaluation of clinical outcomes of prophylactic versus preemptive cytomegalovirus strategy in liver transplant recipients. Transpl Int (2013) 1.50

Tubular expression of heat-shock protein 27 inhibits fibrogenesis in obstructive nephropathy. Kidney Int (2012) 1.50

A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J Virol (2010) 1.50

Selenium-binding protein-1 in smooth muscle cells is downregulated in a rhesus monkey model of chronic allograft nephropathy. Am J Transplant (2005) 1.45

Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation. Am J Respir Crit Care Med (2008) 1.44

Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death. Transpl Int (2008) 1.44

Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant (2004) 1.42

When Do DCD Donors Die?: Outcomes and Implications of DCD at a High-volume, Single-center OPO in the United States. Ann Surg (2016) 1.42

Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol (2008) 1.42

Early activation of the inflammatory response in the liver of brain-dead non-human primates. J Surg Res (2011) 1.40

Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant beta2-microglobulin gene. Proc Natl Acad Sci U S A (2006) 1.39

Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rgammanull mice. Hum Immunol (2010) 1.35

Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med (2004) 1.34

Tolerance to noninherited maternal MHC antigens in mice. J Immunol (2003) 1.33

Donation after cardiac death: the university of wisconsin experience with renal transplantation. Am J Transplant (2004) 1.26

Risk factors and outcomes in post-liver transplantation bile duct stones and casts: A case-control study. Liver Transpl (2008) 1.23

Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am J Transplant (2004) 1.19

Campath-1H in renal transplantation: The University of Wisconsin experience. Surgery (2004) 1.18

Donation after cardiac death: a 29-year experience. Surgery (2011) 1.18

Overcoming Chronic Rejection-Can it B? Transplantation (2009) 1.17

Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. J Immunol (2004) 1.17

Long-term outcomes in pediatric renal transplant recipients who survive into adulthood. Transplantation (2003) 1.14

Donation after cardiac death: the University of Wisconsin experience. Ann Transplant (2004) 1.14

Natural resistance to liver cold ischemia-reperfusion injury associated with the hibernation phenotype. Am J Physiol Gastrointest Liver Physiol (2005) 1.13

Campath-1H use in pediatric renal transplantation. Am J Transplant (2005) 1.13

Mice expressing activated PI3K rapidly develop advanced colon cancer. Cancer Res (2012) 1.12

T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients. Transplantation (2006) 1.12

Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J Immunol (2008) 1.10

An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. J Virol (2012) 1.10

HLA class I noninherited maternal antigens in cord blood and breast milk. Hum Immunol (2004) 1.09

Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. J Immunol (2012) 1.09

Tolerance to noninherited maternal antigens in mice and humans. Curr Opin Organ Transplant (2009) 1.09

Validation of large particle flow cytometry for the analysis and sorting of intact pancreatic islets. Transplantation (2005) 1.08

The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Transpl Int (2006) 1.08

Human NKT cells promote monocyte differentiation into suppressive myeloid antigen-presenting cells. J Leukoc Biol (2009) 1.06

Dendritic cell type determines the mechanism of bystander suppression by adaptive T regulatory cells specific for the minor antigen HA-1. J Immunol (2007) 1.06

Chimerism, tolerance, and twins. Obstet Gynecol (2010) 1.05

CXCR3-mediated T-cell chemotaxis involves ZAP-70 and is regulated by signalling through the T-cell receptor. Immunology (2007) 1.04

Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection. Transplantation (2009) 1.04

Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance. Front Immunol (2013) 1.03

Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention. Am J Transplant (2004) 1.03

Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species. Clin Vaccine Immunol (2008) 1.02